Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-04-04
DOI
https://doi.org/10.1111/apt.70109
Citations
3
Primary Topic
Gastroesophageal reflux and treatments
Type
article
Field-Weighted Citation Impact
5.43
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis

David Armstrong, Maria Rosenholm, A Rosztóczy, Peter Unge et al.
3 citations
Alimentary Pharmacology & Therapeutics
Gastroesophageal reflux and treatments
5.43
article

Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis

David Armstrong, Maria Rosenholm, A Rosztóczy, Peter Unge, Elham Yektaei, Prateek Sharma, Kjell Andersson, Michael F. Vaezi, Kajsa Larsson, Ivan Popadiyn
article en
3 citations

Abstract

No abstract available for this paper.
Alimentary Pharmacology & TherapeuticsVol. 61(10)
University of Kansas (US), Vanderbilt University (US), University of Szeged (HU), Tokuda Hospital (BG), McMaster University (CA)
Good health and well-being
Openalex Percentile: Top 5%
Gastroesophageal reflux and treatments
5.43
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.